Financial Year |
March 31 2023 |
Monetary Funds |
123,009,152.86 |
Held-for-trading Financial Assets |
-- |
Notes Receivable |
380,000.00 |
Accounts Receivable |
449,780,589.48 |
Advances to Suppliers |
10,564,708.05 |
Other Receivables |
399,042.01 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
-- |
Dividend Receivable |
-- |
Inventories |
501,571,244.01 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
-- |
Other Current Assets |
8,663,042.43 |
Total Current Assets |
1,171,094,483.08 |
Available-for-Sale Financial Asset |
-- |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
-- |
Long-term Equity Investment |
-- |
Investment Properties |
-- |
Fixed Assetes |
650,523,873.89 |
Under-construction Projects |
35,876,613.00 |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
-- |
Oil and Gas Assets |
-- |
Intangible Assets |
47,371,063.73 |
R&D expenses |
-- |
Goodwill |
-- |
Long-Term Deferred and Prepaid Expenses |
26,408,114.00 |
Deferred Income Tax Assets |
-- |
Other Non-Current Assets |
1,189,900.00 |
Sub-Total of Non-Current Assets |
764,460,260.82 |
Total Assets |
1,935,554,743.90 |
Short-Term Loans |
377,452,596.55 |
Trading Financial liabilities |
-- |
Notes Payable |
73,659,706.81 |
Accounts Payable |
155,427,259.61 |
Accounts Received In Advance |
280,000.00 |
Employee Compensation Payable |
21,240,023.84 |
Taxes Payable |
2,103,118.15 |
Interest Payable |
-- |
Dividend Payable |
-- |
Other payables |
3,716,234.23 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
1,626,741.17 |
Other Current Liabilities |
25,284.42 |
Sub-Total of Current Liabilities |
635,725,460.36 |
Long-term Loans |
-- |
Bonds Payable |
-- |
Long-Term Accounts Payable |
-- |
Special Payable |
-- |
Estimatied Liabilities |
-- |
Deferred Income Tax Liabilities |
4,018,507.66 |
Other Non-Current Liabilities |
-- |
Sub-Total of Non-Current Liabilities |
22,155,827.94 |
Total Liabilities |
657,881,288.30 |
Paid-In Capital(Or Share Stock) |
215,316,977.00 |
Capital Surplus |
662,755,789.12 |
Surplus Reserve |
57,535,892.33 |
LESS:Treasury Stock |
6,008,164.51 |
Undistributed Profits |
346,253,616.72 |
Minority Stockholder's Interest |
1,227,922.72 |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,276,445,532.88 |
Owner's Equity(Stockholder's Equity) |
1,277,673,455.60 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
1,935,554,743.90 |